Product Description: Foralumab (NI-0401) is a potent, orally active human monoclonal antibody targeting the CD3. Foralumab modulates immune responses by human cells in NSG mice that were reconstituted with human hematopoietic stem cells[1].
Applications: COVID-19-immunoregulation
Formula: N/A
References: [1]Ogura M, et, al. Oral treatment with foralumab, a fully human anti-CD3 monoclonal antibody, prevents skin xenograft rejection in humanized mice. Clin Immunol. 2017 Oct;183:240-246.
CAS Number: 946415-64-1
Molecular Weight: N/A
Compound Purity: 98.08
Research Area: Inflammation/Immunology
Solubility: 10 mM in DMSO
Target: CD3